शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
DRAGARWQBSEDR. AGARWAL'S EYE HOSP L· Healthcare ServicesHighNeutral
Announced Mon, 3 Aug, 2026 · 17:24 IST

Q1 FY27 results: revenue up 22%, PAT up 35%, Cost Auditor re-appointed

Revenue growth above 20%Profit growth above 25%Results View source PDFExplain this filing

DRAGARWQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.4%Reaction day
₹5048.50
prior close
₹5199.50
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-0.0% vs market
Hospital peers, median of 26sector+0.1%+0.3% vs sector

On the reaction day the stock moved in line with Nifty Microcap 250 and 0.3 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+1.9
10m
+1.0
15m
+0.0
30m
-1.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.4+0.4-0.0+0.1+0.3
Next day
+3.0+1.7+1.3+0.0+3.0
2d
+4.1+2.1+2.0+0.2+3.9
3d
+4.2+2.1+2.1+1.2+2.9
4d
+7.0+2.1+4.9+1.0+5.9
5d
+5.5+1.9+3.7-0.7+6.2
1w
+6.0+2.4+3.5-2.2+8.1
15d
+5.2+3.0+2.2-1.5+6.7
1m
+8.0+3.7+4.2-2.9+10.8
2m
+4.0+1.6+2.4-9.2+13.2
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Dr. Agarwal's Eye Hospital posted strong Q1 FY27 results. Revenue from operations rose about 22 percent YoY to INR 142.97 crore versus INR 116.92 crore. Net profit after tax jumped around 35 percent YoY to INR 23.38 crore. EBITDA stood at INR 45.22 crore. EPS rose to INR 48.38. Board also re-appointed M/s. B Y and Associates as Cost Auditors for FY 2026-27. The merger with holding company Dr. Agarwal's Health Care is awaiting NCLT sanction.

Likely market impact

Strong quarterly performance signals healthy business growth; pending merger with parent company could simplify group structure.